Wolverine Asset Management’s Metal Sky Star Acquisition Corporation Ordinary shares MSSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-304,609
Closed -$3.49M 1848
2024
Q3
$3.49M Sell
304,609
-2,137
-0.7% -$24.3K 0.04% 370
2024
Q2
$3.48M Sell
306,746
-6,531
-2% -$73.6K 0.04% 364
2024
Q1
$3.47M Buy
313,277
+57,128
+22% +$631K 0.04% 362
2023
Q4
$2.8M Sell
256,149
-190,539
-43% -$2.08M 0.02% 458
2023
Q3
$4.86M Sell
446,688
-8,768
-2% -$94.6K 0.05% 321
2023
Q2
$5.01M Sell
455,456
-1,001
-0.2% -$10.5K 0.06% 295
2023
Q1
$4.77M Buy
456,457
+963
+0.2% +$9.97K 0.06% 329
2022
Q4
$4.64M Buy
455,494
+51,901
+13% +$522K 0.05% 362
2022
Q3
$4.01M Buy
403,593
+374,793
+1,301% +$3.72M 0.04% 368
2022
Q2
$284K Buy
+28,800
New +$283K ﹤0.01% 1121

Other funds holding MSSA

Wolverine Asset Management's MSSA Position: Q4 2024 in Review

Wolverine Asset Management sold out of Metal Sky Star Acquisition Corporation Ordinary shares (MSSA) in Q4 2024, closing a stake of 304,609 shares — an estimated $3.49M sold.

Wolverine Asset Management first reported a position in MSSA in Q2 2022 and held it in 10 quarters. The position peaked at $5.01M in Q2 2023. 4 funds tracked by Wall St. Rank hold MSSA as of Q4 2024.

  • Wolverine Asset Management reported no remaining Metal Sky Star Acquisition Corporation Ordinary shares position as of Q4 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 304,609 Metal Sky Star Acquisition Corporation Ordinary shares shares in Q4 2024, an estimated $3.49M.
  • Wolverine Asset Management first reported a position in Metal Sky Star Acquisition Corporation Ordinary shares in Q2 2022 and held it in 10 quarters.
  • Wolverine Asset Management's Metal Sky Star Acquisition Corporation Ordinary shares position peaked at $5.01M in Q2 2023.
  • 4 funds tracked by Wall St. Rank held Metal Sky Star Acquisition Corporation Ordinary shares as of Q4 2024.

Based on Wolverine Asset Management's 13F filing for Q4 2024, filed 3 Feb 2025.